| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.6823565 |
| P698 | PubMed publication ID | 6823565 |
| P2093 | author name string | Anderson MW | |
| Kaplan NL | |||
| Hoel DG | |||
| P433 | issue | 4588 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1032-1037 | |
| P577 | publication date | 1983-03-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Implication of nonlinear kinetics on risk estimation in carcinogenesis. | |
| P478 | volume | 219 |
| Q58071763 | 15 Environmental biometry: Assessing impacts of environmental stimuli via animal and microbial laboratory studies |
| Q34841737 | A model-free approach to low-dose extrapolation |
| Q40438417 | A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments |
| Q39647985 | Absorption and distribution of xenobiotics |
| Q28393946 | Air samples versus biomarkers for epidemiology |
| Q51118711 | Alternative Multiorgan Initiation-Promotion Assay for Chemical Carcinogenesis in the Wistar Rat. |
| Q39512374 | Applications and mode of action of formaldehyde condensate biocides |
| Q39650387 | Are there thresholds for carcinogenesis? The thorny problem of low-level exposure |
| Q34660343 | Assessing the effects of metabolism of environmental agents on cancer tumor development by a two-stage model of carcinogenesis |
| Q36841034 | Assessment of safety/risk of chemicals: inception and evolution of the ADI and dose-response modeling procedures |
| Q28768656 | Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens |
| Q50202477 | Cost-effectiveness of short-term tests for carcinogenicity |
| Q34660243 | DNA adducts as a dosimeter for risk estimation |
| Q72746840 | Differentiation between metabolic incorporation and covalent binding in the labeling of macromolecules in the rat nasal mucosa and bone marrow by inhaled [14C]- and [3H]formaldehyde |
| Q53546559 | Dose relationships in experimental carcinogenesis: dependence on multiple factors including biotransformation. |
| Q34660669 | Dose-response relationships for carcinogens: a review |
| Q68031037 | Effect of ten thiocompounds on rat liver DNA damage induced by a small dose of N-nitrosodimethylamine |
| Q34128970 | Employing a Mechanistic Model for the MAPK Pathway to Examine the Impact of Cellular all or None Behavior on Overall Tissue Response. |
| Q35035701 | Examination of adduct formation in vivo in the mouse between benzo(a)pyrene and DNA of skin and hemoglobin of red blood cells |
| Q50201678 | Health-risk estimates for 2,3,7,8-tetrachloro-dibenzodioxin: an overview |
| Q35034304 | Hematotoxicity and carcinogenicity of inhaled benzene |
| Q34660257 | High- to low-dose extrapolation: critical determinants involved in the dose response of carcinogenic substances |
| Q34660069 | Implications of pharmacokinetic modeling in risk assessment analysis |
| Q34660482 | Issues and current applications of interspecies extrapolation of carcinogenic potency as a component of risk assessment |
| Q37132981 | Low-dose radiation and genotoxic chemicals can protect against stochastic biological effects |
| Q40203763 | Mechanisms of chemical carcinogenesis: recent advances |
| Q35034348 | Metabolite-based internal doses used in a risk assessment of benzene |
| Q35031183 | Nonlinearity of dose-response functions for carcinogenicity |
| Q34660528 | Opportunities for improving techniques for interspecies extrapolation in the risk assessment process |
| Q39665059 | Overdose toxicity studies versus threshold: elements of biology must be incorporated into risk assessment |
| Q37969569 | Quantitative factors in chemical carcinogenesis: variation in carcinogenic potency |
| Q35035881 | Relationships between DNA adduct formation and carcinogenesis |
| Q40567600 | Review of the metabolic fate of styrene |
| Q26343291 | Risk assessment and occupational health: overview and recommendations |
| Q37948902 | Risk assessment of carcinogenic and noncarcinogenic chemicals |
| Q34940048 | Risk assessment of low-level chemical exposures from consumer products under the U.S. Consumer Product Safety Commission chronic hazard guidelines |
| Q43733201 | Species correlation of chemical carcinogens |
| Q40177695 | The genotoxic/epigenetic distinction: Relevance to cancer policy |
| Q39153812 | The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective |
| Q68318467 | The modulation of oxygen toxicity by intermittent exposure |
| Q38694726 | The question of thresholds for radiation and chemical carcinogenesis |
| Q34640134 | Topics in cancer risk assessment |
| Q35035789 | Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells |
| Q39777682 | Utilization of the quantitative component of the information obtained from short term tests |
Search more.